Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials

Cancer Patients ◽

Braf Mutation ◽

Clinical Impact ◽

First Line ◽

Mutation Dynamics ◽

Faculty Opinions recommendation of Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726943980.793538773 ◽

2017 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Iii ◽

First Line ◽

Phase Iii Study ◽

Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy

Journal of Cancer ◽

10.7150/jca.44580 ◽

2020 ◽

Vol 11 (22) ◽

pp. 6507-6515

Author(s):

Lu Jiang ◽

Shuwei Li ◽

Ming Yuan ◽

Ling Ma ◽

Yu Lin ◽

...

Keyword(s):

Colorectal Cancer ◽

Folic Acid ◽

Cancer Patients ◽

Metabolic Pathway ◽

Genetic Variants ◽

First Line ◽

P-272 Sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy

Annals of Oncology ◽

10.1016/j.annonc.2020.04.354 ◽

2020 ◽

Vol 31 ◽

pp. S178

Author(s):

C. Maddalena ◽

A. Ponsiglione ◽

L. Camera ◽

L. Santarpia ◽

F. Pasanisi ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

First Line ◽

Optimizing the use of first-line chemotherapy in metastatic colorectal cancer patients with mucinous histology. A multicenter, retrospective, combined analysis on 897 patients

Annals of Oncology ◽

10.1093/annonc/mdy150.014 ◽

2018 ◽

Vol 29 ◽

pp. v97

Author(s):

V. Catalano ◽

F. Bergamo ◽

C. Cremolini ◽

B. Vincenzi ◽

F. Negri ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

First Line ◽

Combined Analysis ◽

Mucinous Histology ◽

Clinical correlation between <i>in vitro</i> chemoresponse assay and first line chemotherapy for metastatic colorectal cancer patients

Korean Journal of Clinical Oncology ◽

10.14216/kjco.15010 ◽

2015 ◽

Vol 11 (2) ◽

pp. 51-58 ◽

Cited By ~ 1

Author(s):

Sang Hun Jung ◽

So Hyun Kim ◽

Jae Hwang Kim

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Clinical Correlation ◽

First Line ◽

Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

BMC Cancer ◽

10.1186/s12885-018-5252-2 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 9

Author(s):

Jinjia Chang ◽

Guangyi Lin ◽

Min Ye ◽

Duo Tong ◽

Jing Zhao ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Mean Platelet Volume ◽

Poor Prognosis ◽

First Line ◽

Platelet Volume ◽

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

BMC Cancer ◽

10.1186/s12885-015-1751-6 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 1

Author(s):

Hiroki Osumi ◽

Eiji Shinozaki ◽

Mitsukuni Suenaga ◽

Yosuke Kumekawa ◽

Mariko Ogura ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

First Line ◽

Line Chemotherapy ◽

P53 Antibody

Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab

Annals of Oncology ◽

10.1093/annonc/mdr365 ◽

2012 ◽

Vol 23 (4) ◽

pp. 919-927 ◽

Cited By ~ 28

Author(s):

D. Malka ◽

V. Boige ◽

N. Jacques ◽

N. Vimond ◽

A. Adenis ◽

...

Keyword(s):

Colorectal Cancer ◽

Endothelial Cell ◽

Cancer Patients ◽

First Line ◽

Clinical Value ◽

Faculty Opinions recommendation of Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726943980.793525581 ◽

2016 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Iii ◽

First Line ◽

Phase Iii Study ◽

Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e14646 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e14646-e14646

Author(s):

Kezban Nur Pilanci ◽

Sezer Saglam ◽

Alper Okyar ◽

Serap Yucel ◽

Zeliha Pala Kara ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

First Line ◽